Parsing the deadliness of prostate cancer Prostate cancers are not all the same. Some are extremely aggressive: They can and do kill. Others are slow-growing and don’t kill: Men die with them, not of them. How can doctors and patients discern which one is which? Fred Hutch's Dr. Janet Stanford believes she may have found a way. Sept. 4, 2018 in Hutch News
Dr. James Dai receives $2.1M NCI grant for cancer biomarker research Fred Hutch biostatistician Dr. James Dai recently was awarded a $2.1 million grant from the National Cancer Institute to develop new analytical methods for identifying genetic and epigenetic alterations that drive cancers. He hopes this work will facilitate the discovery of molecular cancer drivers — biomarkers — and the development of new preventive, diagnostic and prognostic techniques. Aug. 20, 2018 in Hutch News
Supper, sleep, circadian rhythms and cancer risk A new study out of Barcelona suggests when you eat may be just as critical as what you eat, at least with regard to breast and prostate cancer risk. We sat down with principal investigator Dr. Manolis Kogevinas, currently a visiting professor at Fred Hutch, for his insights on how circadian disruption can impact our health. July 19, 2018 in Hutch News
Fred Hutch is proud to be an Equal Opportunity and VEVRAA Employer. We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability, marital or veteran status, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. Read the EEO is the Law poster here.